Outcomes of Nintedanib in Children and Adolescents With Fibrosing Interstitial Lung Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nintedanib in children and adolescents with fibrosing interstitial lung diseases
Eur. Respir. J. 2023 Feb 01;[EPub Ahead of Print], R Deterding, LR Young, EM DeBoer, D Warburton, S Cunningham, N Schwerk, KR Flaherty, KK Brown, M Dumistracel, E Erhardt, J Bertulis, M Gahlemann, S Stowasser, M GrieseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.